Abstract The diagnosis of metabolic syndrome Assessmennt focuses on the assessment of Metabolic syndrome risk assessment factors such as insulin Metabplic, dyslipidemia, central adiposity and elevated blood pressure. Abstract We assessed the risk of metabolic syndrome in children and adolescents who were classified using the tri-ponderal mass index TMI with data from the Korea National Health and Nutrition Examination Survey KNHANES. KG, Nümbrecht, Germany.

Metabolic syndrome risk assessment -

Banting lecture Role of insulin resistance in human disease. Saklayen MG. The global epidemic of the metabolic syndrome. Curr Hypertens Rep. Sattar N, McConnachie A, Shaper AG, et al. Can metabolic syndrome usefully predict cardiovascular disease and diabetes?

Outcome data from two prospective studies. Shah AD, Langenberg C, Rapsomaniki E, et al. Type 2 diabetes and incidence of cardiovascular diseases: a cohort study in 1·9 million people. Stamler J, Vaccaro O, Neaton JD, Wentworth D.

Diabetes, other risk factors, and yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial.

Stevens RJ, Kothari V, Adler AI, Stratton IM, United Kingdom Prospective Diabetes Study UKPDS Group. The UKPDS risk engine: a model for the risk of coronary heart disease in type II diabetes UKPDS Clin Sci Lond.

Suh DC, Choi IS, Plauschinat C, Kwon J, Baron M. J Diabetes Complications. Turner RC, Millns H, Neil HA, et al. Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study UKPDS: Ueda P, Woodward M, Lu Y, et al.

Laboratory-based and office-based risk scores and charts to predict year risk of cardiovascular disease in countries: a pooled analysis of prospective cohorts and health surveys. Epub Jan PMID: ; PMCID: PMC Vu JD, Vu JB, Pio JR, Malik S, Franklin SS, Chen RS, Wong ND. Impact of C-reactive protein on the likelihood of peripheral arterial disease in United States adults with the metabolic syndrome, diabetes mellitus, and preexisting cardiovascular disease.

Wilson PW. Diabetes mellitus and coronary heart disease. Endocrinol Metab Clin North Am. Wong ND, Sciammarella MG, Polk D, et al.

The metabolic syndrome, diabetes, and subclinical atherosclerosis assessed by coronary calcium. Preventing coronary events by optimal control of blood pressure and lipids in patients with the metabolic syndrome.

Wong ND, Glovaci D, Wong K, Malik S, Franklin SS, Wygant G, Iloeje U. Global cardiovascular disease risk assessment in United States adults with diabetes. Diab Vasc Dis Res. Wong ND, Nelson JC, Granston T, et al. Metabolic syndrome, diabetes, and incidence and progression of coronary calcium: the Multiethnic Study of Atherosclerosis study.

JACC Cardiovasc Imaging. Wong ND, Zhao Y, Patel R, et al. Cardiovascular risk factor targets and cardiovascular disease event risk in diabetes: a pooling project of the Atherosclerosis Risk in Communities Study, Multi-Ethnic Study of Atherosclerosis, and Jackson Heart Study.

Yang X, So WY, Kong AP, et al. Development and validation of a total coronary heart disease risk score in type 2 diabetes mellitus.

Yang P, Zhao Y, Wong ND. Development of a risk score for atrial fibrillation in adults with diabetes mellitus from the ACCORD study. Yeboah J, Erbel R, Delaney JC, et al. Development of a new diabetes risk prediction tool for incident coronary heart disease events: the Multi-Ethnic Study of Atherosclerosis and the Heinz Nixdorf Recall Study.

Zhao Y, Wong ND. The evolving cardiovascular disease risk scores for persons with diabetes mellitus. Curr Cardio Rep. Download references. Heart Disease Prevention Program, Division of Cardiology, University of California, Irvine, CA, USA. You can also search for this author in PubMed Google Scholar.

Correspondence to Nathan D. Section on Cardiovascular Disease, Wake Forest University School of Medicine, Winston Salem, NC, USA. Reprints and permissions. Wong, N. Cardiovascular Risk Assessment in Metabolic Syndrome and Diabetes. In: Shapiro, M. eds Cardiovascular Risk Assessment in Primary Prevention.

Contemporary Cardiology. Humana, Cham. Published : 27 May Publisher Name : Humana, Cham. Print ISBN : Online ISBN : eBook Packages : Medicine Medicine R0. Anyone you share the following link with will be able to read this content:.

Sorry, a shareable link is not currently available for this article. Provided by the Springer Nature SharedIt content-sharing initiative. Policies and ethics. Skip to main content. Abstract Metabolic syndrome and diabetes are associated with increased risks for cardiovascular diseases.

Keywords Metabolic syndrome Diabetes Cardiovascular disease Risk assessment. Buying options Chapter EUR eBook EUR Softcover Book EUR Hardcover Book EUR Tax calculation will be finalised at checkout Purchases are for personal use only Learn about institutional subscriptions. References Alberti KG, Eckel RH, Grundy SM, et al.

Google Scholar Andary R, Fan W, Wong ND. Article PubMed Google Scholar Anselmino M, Mellbin L, Wallander M, Rydén L. PubMed Google Scholar Basu S, Sussman JB, Berkowitz SA, Hayward RA, Yudkin JS. Article PubMed PubMed Central Google Scholar Biondi-Zoccai GG, Abbate A, Liuzzo G, Biasucci LM.

Article CAS PubMed Google Scholar Bittner V, Bertolet M, Barraza Felix R, et al. Article PubMed PubMed Central Google Scholar Bulugahapitiya U, Siyambalapitiya S, Sithole J, Idris I. Article CAS PubMed Google Scholar Cederholm J, Eeg-Olofsson K, Eliasson B, et al.

Article PubMed Google Scholar Conroy RM, Pyörälä K, Fitzgerald AP, et al. Article CAS PubMed Google Scholar Donnan PT, Donnelly L, New JP, Morris AD. Article PubMed Google Scholar Dunkley AJ, Charles K, Gray LJ, Camosso-Stefinovic J, Davies MJ, Khunti K.

Privacy Policy Terms of Use. Access your subscriptions. Free access to newly published articles. Purchase access.

Rent article Rent this article from DeepDyve. Sign in to access free PDF. Save your search. Customize your interests. Create a personal account or sign in to:.

Privacy Policy. To provide you with the most relevant and helpful information, and understand which information is beneficial, we may combine your email and website usage information with other information we have about you.

If you are a Mayo Clinic patient, this could include protected health information. If we combine this information with your protected health information, we will treat all of that information as protected health information and will only use or disclose that information as set forth in our notice of privacy practices.

You may opt-out of email communications at any time by clicking on the unsubscribe link in the e-mail. Metabolic syndrome is closely linked to overweight or obesity and inactivity. The following factors increase your chances of having metabolic syndrome: Age. Your risk of metabolic syndrome increases with age.

In the United States, Hispanics — especially Hispanic women — appear to be at the greatest risk of developing metabolic syndrome.

The reasons for this are not entirely clear. Carrying too much weight, especially in your abdomen, increases your risk of metabolic syndrome. You're more likely to have metabolic syndrome if you had diabetes during pregnancy gestational diabetes or if you have a family history of type 2 diabetes.

Other diseases. Your risk of metabolic syndrome is higher if you've ever had nonalcoholic fatty liver disease, polycystic ovary syndrome or sleep apnea. Having metabolic syndrome can increase your risk of developing: Type 2 diabetes.

If you don't make lifestyle changes to control your excess weight, you may develop insulin resistance, which can cause your blood sugar levels to rise. Eventually, insulin resistance can lead to type 2 diabetes. Heart and blood vessel disease. High cholesterol and high blood pressure can contribute to the buildup of plaques in your arteries.

These plaques can narrow and harden your arteries, which can lead to a heart attack or stroke. A healthy lifestyle includes: Getting at least 30 minutes of physical activity most days Eating plenty of vegetables, fruits, lean protein and whole grains Limiting saturated fat and salt in your diet Maintaining a healthy weight Not smoking.

By Mayo Clinic Staff. May 06, Show References. Ferri FF. Metabolic syndrome. In: Ferri's Clinical Advisor Elsevier; Accessed March 1, National Heart, Lung, and Blood Institute. Metabolic syndrome syndrome X; insulin resistance syndrome. Merck Manual Professional Version.

March 2, About metabolic syndrome. American Heart Association.

The Powerful Antioxidant Foods Manage hunger cravings MetS is a clustering of risk factors known to assexsment or increase the Powerful Antioxidant Foods assessment Metabolic syndrome risk assessment of diabetes mellitus and cardiovascular disease CVD. Approximately one-third of assessmentt Powerful Antioxidant Foods population of developed countries can be categorized as having MetS by different definitions. MetS, Metabolic syndrome risk assessment in the Metabolid of diabetes mellitus, is associated syndroms an increased risk of CVD and total mortality. Those with diabetes mellitus are considered a cardiovascular risk equivalent and warrant aggressive management of underlying risk factors to optimize prevention of CVD. Initial evaluation of coronary heart disease risk involves global risk estimation using Framingham or other algorithms for risk prediction. Consideration of screening for novel risk factors such as C-reactive protein, as well as subclinical atherosclerosis from carotid ultrasound, computed tomography, or ankle-brachial indexcan further refine the estimation of future CVD risk. The presence of subclinical atherosclerosis or elevated levels of C-reactive protein can potentially modify recommended treatment goals for lipid and other cardiovascular risk factors. Kohli P Assesament, Greenland P. Role of the Metabolic Fisk in Risk Powerful Antioxidant Foods for Coronary Heart Disease. Artificial Intelligence Resource Center. Featured Clinical Reviews Screening for Atrial Fibrillation: US Preventive Services Task Force Recommendation Statement JAMA. X Facebook LinkedIn. This Issue. Citations

Metabolic syndrome risk assessment -

View Metrics. Share X Facebook Email LinkedIn. From the Archives Journals. Priya Kohli, MD ; Philip Greenland, MD. Article Information. visual abstract icon Visual Abstract. This Week in JAMA. Access through your institution. Add or change institution. Download PDF Full Text Cite This Citation Kohli P , Greenland P.

Select Your Interests Customize your JAMA Network experience by selecting one or more topics from the list below. Save Preferences. Privacy Policy Terms of Use. Access your subscriptions. Free access to newly published articles. Jahangiry L, Farhangi MA, Rezaei F.

Framingham risk score for estimate of years of cardiovascular diseases risk in patients with metabolic syndrome. J Health Popul Nutr. Knuiman MW, Hung J, Divitini ML, Davis TM, Beilby JP. Utility of the metabolic syndrome and its components in the prediction of incident cardiovascular disease: a prospective cohort study.

Eur J Cardiovasc Prev Rehabil. Levantesi G, Macchia A, Marfisi R, et al. Metabolic syndrome and risk of cardiovascular events after myocardial infarction. Mach F, Baigent C, Catapano AL, et al. Malik S, Wong ND, Franklin SS, et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults.

Malik S, Wong ND, Franklin S, Pio J, Fairchild C, Chen R. Cardiovascular disease in U. patients with metabolic syndrome, diabetes, and elevated C-reactive protein. Malik S, Budoff MJ, Katz R, et al.

Impact of subclinical atherosclerosis on cardiovascular disease events in individuals with metabolic syndrome and diabetes: the multi-ethnic study of atherosclerosis. Malik S, Zhao Y, Budoff M, et al. Coronary artery calcium score for long-term risk classification in individuals with type 2 diabetes and metabolic syndrome from the Multi-ethnic Study of Atherosclerosis.

JAMA Cardiol. National Cholesterol Education Program NCEP Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults Adult Treatment Panel III.

Third Report of the National Cholesterol Education Program NCEP Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults Adult Treatment Panel III final report.

Parrinello CM, Matsushita K, Woodward M, Wagenknecht LE, Coresh J, Selvin E. Risk prediction of major complications in individuals with diabetes: the Atherosclerosis Risk in Communities Study.

Pyorala K, De Backer G, Graham I, Poole-Wilson P, Wood D. Prevention of coronary heart disease in clinical practice. Recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension.

CAS PubMed Google Scholar. Raggi P, Shaw LJ, Berman DS, Callister TQ. Prognostic value of coronary artery calcium screening in subjects with and without diabetes. Rana JS, Liu JY, Moffet HH, Jaffe M, Karter AJ. Diabetes and prior coronary heart disease are not necessarily risk equivalent for future coronary heart disease events.

J Gen Intern Med. Rawshani A, Rawshani A, Franzén S, et al. Risk factors, mortality, and cardiovascular outcomes in patients with type 2 diabetes. Rawshani A, Rawshani A, Sattar N, et al. Relative prognostic importance and optimal levels of risk factors for mortality and cardiovascular outcomes in type 1 diabetes mellitus.

Reaven GM. Banting lecture Role of insulin resistance in human disease. Saklayen MG. The global epidemic of the metabolic syndrome. Curr Hypertens Rep. Sattar N, McConnachie A, Shaper AG, et al.

Can metabolic syndrome usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studies. Shah AD, Langenberg C, Rapsomaniki E, et al. Type 2 diabetes and incidence of cardiovascular diseases: a cohort study in 1·9 million people. Stamler J, Vaccaro O, Neaton JD, Wentworth D.

Diabetes, other risk factors, and yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Stevens RJ, Kothari V, Adler AI, Stratton IM, United Kingdom Prospective Diabetes Study UKPDS Group.

The UKPDS risk engine: a model for the risk of coronary heart disease in type II diabetes UKPDS Clin Sci Lond. Suh DC, Choi IS, Plauschinat C, Kwon J, Baron M.

J Diabetes Complications. Turner RC, Millns H, Neil HA, et al. Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study UKPDS: Ueda P, Woodward M, Lu Y, et al.

Laboratory-based and office-based risk scores and charts to predict year risk of cardiovascular disease in countries: a pooled analysis of prospective cohorts and health surveys. Epub Jan PMID: ; PMCID: PMC Vu JD, Vu JB, Pio JR, Malik S, Franklin SS, Chen RS, Wong ND. Impact of C-reactive protein on the likelihood of peripheral arterial disease in United States adults with the metabolic syndrome, diabetes mellitus, and preexisting cardiovascular disease.

Wilson PW. Diabetes mellitus and coronary heart disease. Endocrinol Metab Clin North Am. Wong ND, Sciammarella MG, Polk D, et al. The metabolic syndrome, diabetes, and subclinical atherosclerosis assessed by coronary calcium.

Preventing coronary events by optimal control of blood pressure and lipids in patients with the metabolic syndrome. Wong ND, Glovaci D, Wong K, Malik S, Franklin SS, Wygant G, Iloeje U. Global cardiovascular disease risk assessment in United States adults with diabetes.

Diab Vasc Dis Res. Wong ND, Nelson JC, Granston T, et al. Metabolic syndrome, diabetes, and incidence and progression of coronary calcium: the Multiethnic Study of Atherosclerosis study. JACC Cardiovasc Imaging. Wong ND, Zhao Y, Patel R, et al.

Cardiovascular risk factor targets and cardiovascular disease event risk in diabetes: a pooling project of the Atherosclerosis Risk in Communities Study, Multi-Ethnic Study of Atherosclerosis, and Jackson Heart Study.

Yang X, So WY, Kong AP, et al. Development and validation of a total coronary heart disease risk score in type 2 diabetes mellitus. Yang P, Zhao Y, Wong ND. Development of a risk score for atrial fibrillation in adults with diabetes mellitus from the ACCORD study.

Yeboah J, Erbel R, Delaney JC, et al. Development of a new diabetes risk prediction tool for incident coronary heart disease events: the Multi-Ethnic Study of Atherosclerosis and the Heinz Nixdorf Recall Study.

Zhao Y, Wong ND. The evolving cardiovascular disease risk scores for persons with diabetes mellitus. Curr Cardio Rep. Download references. Heart Disease Prevention Program, Division of Cardiology, University of California, Irvine, CA, USA.

You can also search for this author in PubMed Google Scholar. Correspondence to Nathan D. Section on Cardiovascular Disease, Wake Forest University School of Medicine, Winston Salem, NC, USA.

Reprints and permissions. Wong, N. Cardiovascular Risk Assessment in Metabolic Syndrome and Diabetes. In: Shapiro, M. eds Cardiovascular Risk Assessment in Primary Prevention.

Contemporary Cardiology. Humana, Cham. Published : 27 May Publisher Name : Humana, Cham. Print ISBN : Online ISBN : eBook Packages : Medicine Medicine R0. Anyone you share the following link with will be able to read this content:.

Sorry, a shareable link is not currently available for this article. Provided by the Springer Nature SharedIt content-sharing initiative. Policies and ethics. Skip to main content. Abstract Metabolic syndrome and diabetes are associated with increased risks for cardiovascular diseases. Keywords Metabolic syndrome Diabetes Cardiovascular disease Risk assessment.

Buying options Chapter EUR eBook EUR Softcover Book EUR Hardcover Book EUR Tax calculation will be finalised at checkout Purchases are for personal use only Learn about institutional subscriptions.

References Alberti KG, Eckel RH, Grundy SM, et al. Google Scholar Andary R, Fan W, Wong ND. Article PubMed Google Scholar Anselmino M, Mellbin L, Wallander M, Rydén L. PubMed Google Scholar Basu S, Sussman JB, Berkowitz SA, Hayward RA, Yudkin JS.

Article PubMed PubMed Central Google Scholar Biondi-Zoccai GG, Abbate A, Liuzzo G, Biasucci LM. Article CAS PubMed Google Scholar Bittner V, Bertolet M, Barraza Felix R, et al.

Article PubMed PubMed Central Google Scholar Bulugahapitiya U, Siyambalapitiya S, Sithole J, Idris I. Article CAS PubMed Google Scholar Cederholm J, Eeg-Olofsson K, Eliasson B, et al.

Article PubMed Google Scholar Conroy RM, Pyörälä K, Fitzgerald AP, et al. Article CAS PubMed Google Scholar Donnan PT, Donnelly L, New JP, Morris AD. Article PubMed Google Scholar Dunkley AJ, Charles K, Gray LJ, Camosso-Stefinovic J, Davies MJ, Khunti K.

Article Google Scholar Emerging Risk Factors Collaboration. Article CAS Google Scholar Fagan TC, Deedwania PC. Article CAS PubMed Google Scholar Fan W, Song Y, Inzucchi SE, et al. Article CAS PubMed Google Scholar Foley RN, Murray AM, Li S, et al. Article PubMed Google Scholar Gaede P, Lund-Andersen H, Parving HH, Pedersen O.

Article CAS PubMed Google Scholar Gæde P, Oellgaard J, Carstensen B, et al. Article PubMed PubMed Central CAS Google Scholar Gami AS, Witt BJ, Howard DE, et al.

Article CAS PubMed Google Scholar Geiss LS, Herman WH, Smith PJ.

Powerful Antioxidant Foods co-occurrence of metabolic risk factors for both type Powerful Antioxidant Foods diabetes and CVD abdominal obesity, hyperglycemia, dyslipidemia, and hypertension suggested the syndfome of a assfssment syndrome" [ rizk, Powerful Antioxidant Foods. Fisk names applied to Metabolic syndrome risk assessment constellation of Organic Vitamin Supplement have included syndrome X, the Brown rice varieties resistance syndrome, the deadly quartet, or the obesity dyslipidemia syndrome [ 12 ]. Body fat distribution, a sedentary lifestyle, and genetic predisposition all affect the likelihood that an individual with obesity will develop diabetes or CVD. It should be noted that questions have been raised as to whether metabolic syndrome captures any unique pathophysiology implied by calling it a "syndrome" and whether metabolic syndrome confers risk beyond its individual components. These questions raise uncertainty about the value of diagnosing metabolic syndrome in individual patients [ 13,14 ]. These arguments will be reviewed at the end of this discussion see 'A critical look at the metabolic syndrome' below.